Protective Effects of Rifampicin and Its Analog Rifampicin Quinone in a Mouse Model of Obesity-Induced Type 2 Diabetes | ACS Pharmacology & Translational Science
![Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles | ACS Nano Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.1c05099/asset/images/large/nn1c05099_0006.jpeg)
Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles | ACS Nano
![Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB) - ScienceDirect Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1040842820301165-gr2.jpg)
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB) - ScienceDirect
![Molecular basis of the alternative recruitment of GABAA versus glycine receptors through gephyrin | Nature Communications Molecular basis of the alternative recruitment of GABAA versus glycine receptors through gephyrin | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms6767/MediaObjects/41467_2014_Article_BFncomms6767_Fig4_HTML.jpg)
Molecular basis of the alternative recruitment of GABAA versus glycine receptors through gephyrin | Nature Communications
![Lipid‐based nucleic acid therapeutics with in vivo efficacy - Sufian - 2023 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library Lipid‐based nucleic acid therapeutics with in vivo efficacy - Sufian - 2023 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library](https://wires.onlinelibrary.wiley.com/cms/asset/b4042269-a458-49a1-b61f-6322e4dbdab8/wnan1856-toc-0001-m.jpg)
Lipid‐based nucleic acid therapeutics with in vivo efficacy - Sufian - 2023 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library
![Light-Responsive Fusion Proteins For Controlling Binding To Targets Toettcher; Jared ; et al. [The Trustees of Princeton University] Light-Responsive Fusion Proteins For Controlling Binding To Targets Toettcher; Jared ; et al. [The Trustees of Princeton University]](https://uspto.report/patent/app/20200291075/US20200291075A1-20200917-D00000.png)